The board of directors of PuraPharm Corporation Limited announced that with effect from 15 November 2017, Mr. Chan Kin Man, Eddie has been re-designated from a non-executive Director to an executive Director. Mr. Eddie Chan has over 30 years of extensive experience in professional accounting and taxation services. He is the founder and senior partner in CWCC. Following the re-designation of Mr. Eddie Chan from a non-executive Director to an executive Director and his resignation as member of the audit committee of the Board on 15 November 2017, Dr. Chan Kin Keung, Eugene, an independent non-executive Director, was appointed as member of the audit committee of the Board on the same day.